2004, Biotechnology, ISBN 0971176760, Volume 2., xxx, 686
Book
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1183 - 1192
Summary Background We studied the effect on tumour response to neoadjuvant therapy of the substitution of lapatinib for trastuzumab in combination with weekly...
Hematology, Oncology and Palliative Medicine | SURVIVAL | WOMEN | CELLS | SURGICAL ADJUVANT BREAST | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | GW572016 | CHEMOTHERAPY PLUS TRASTUZUMAB | PERTUZUMAB | INHIBITOR | DOCETAXEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | United States | Humans | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Breast Neoplasms - enzymology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Mastectomy | Female | Neoadjuvant Therapy | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Drug Administration Schedule | Logistic Models | Treatment Outcome | Chi-Square Distribution | Breast Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Quinazolines - adverse effects | Trastuzumab | Health maintenance organizations | Neoadjuvant therapy | Medical colleges | Care and treatment | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Breast cancer | Product development | Public health | Cancer | Index Medicus
Hematology, Oncology and Palliative Medicine | SURVIVAL | WOMEN | CELLS | SURGICAL ADJUVANT BREAST | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | GW572016 | CHEMOTHERAPY PLUS TRASTUZUMAB | PERTUZUMAB | INHIBITOR | DOCETAXEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | United States | Humans | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Breast Neoplasms - enzymology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Mastectomy | Female | Neoadjuvant Therapy | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Drug Administration Schedule | Logistic Models | Treatment Outcome | Chi-Square Distribution | Breast Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Quinazolines - adverse effects | Trastuzumab | Health maintenance organizations | Neoadjuvant therapy | Medical colleges | Care and treatment | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Breast cancer | Product development | Public health | Cancer | Index Medicus
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2007, Volume 337, Issue 1, pp. 1 - 24
Interest in intranasal (IN) administration as a non-invasive route for drug delivery continues to grow rapidly. The nasal mucosa offers numerous benefits as a...
Intranasal drug delivery | Pharmacokinetics | Nasal mucosa | Physicochemical properties | IN-VIVO BIOAVAILABILITY | DEPENDENT DIABETIC-PATIENTS | DIMETHYL-BETA-CYCLODEXTRIN | DIFFERENT MOLECULAR-WEIGHTS | NORKETAMINE PLASMA-CONCENTRATIONS | intranasal drug delivery | physicochemical properties | pharmacokinetics | nasal mucosa | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | ACUTE CHILDHOOD SEIZURES | CSF FOLLOWING INTRANASAL | NASAL DRUG-DELIVERY | WATER-SOLUBLE COMPOUNDS | Cholinesterase Inhibitors - pharmacokinetics | Hypnotics and Sedatives - chemistry | Central Nervous System - metabolism | Molecular Weight | Humans | Vaccines - pharmacokinetics | Cholinesterase Inhibitors - chemistry | Hypnotics and Sedatives - administration & dosage | Antiemetics - administration & dosage | Analgesics - pharmacokinetics | Antiemetics - pharmacokinetics | Inflammation - metabolism | Vaccines - chemistry | Cardiovascular Agents - pharmacokinetics | Drug Compounding | Antiemetics - chemistry | Nasal Mucosa - metabolism | Cardiovascular Agents - administration & dosage | Drug Administration Schedule | Hypnotics and Sedatives - pharmacokinetics | Drug Stability | Solubility | Analgesics - administration & dosage | Administration, Intranasal | Chemistry, Pharmaceutical | Carrier Proteins - metabolism | Cholinesterase Inhibitors - administration & dosage | Analgesics - chemistry | Hydrophobic and Hydrophilic Interactions | Vaccines - administration & dosage | Cardiovascular Agents - chemistry
Intranasal drug delivery | Pharmacokinetics | Nasal mucosa | Physicochemical properties | IN-VIVO BIOAVAILABILITY | DEPENDENT DIABETIC-PATIENTS | DIMETHYL-BETA-CYCLODEXTRIN | DIFFERENT MOLECULAR-WEIGHTS | NORKETAMINE PLASMA-CONCENTRATIONS | intranasal drug delivery | physicochemical properties | pharmacokinetics | nasal mucosa | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | ACUTE CHILDHOOD SEIZURES | CSF FOLLOWING INTRANASAL | NASAL DRUG-DELIVERY | WATER-SOLUBLE COMPOUNDS | Cholinesterase Inhibitors - pharmacokinetics | Hypnotics and Sedatives - chemistry | Central Nervous System - metabolism | Molecular Weight | Humans | Vaccines - pharmacokinetics | Cholinesterase Inhibitors - chemistry | Hypnotics and Sedatives - administration & dosage | Antiemetics - administration & dosage | Analgesics - pharmacokinetics | Antiemetics - pharmacokinetics | Inflammation - metabolism | Vaccines - chemistry | Cardiovascular Agents - pharmacokinetics | Drug Compounding | Antiemetics - chemistry | Nasal Mucosa - metabolism | Cardiovascular Agents - administration & dosage | Drug Administration Schedule | Hypnotics and Sedatives - pharmacokinetics | Drug Stability | Solubility | Analgesics - administration & dosage | Administration, Intranasal | Chemistry, Pharmaceutical | Carrier Proteins - metabolism | Cholinesterase Inhibitors - administration & dosage | Analgesics - chemistry | Hydrophobic and Hydrophilic Interactions | Vaccines - administration & dosage | Cardiovascular Agents - chemistry
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 04/2010, Volume 2010, Issue Issue 1, pp. 151 - 158
Pinky Agarwal1, Alida Griffith1, Henry R Costantino2, Narendra Vaish31Booth Gardner Parkinson’s Center, Kirkland, WA, USA; 2Costantino Consulting,...
Journal Article
Biomaterials, ISSN 0142-9612, 05/2005, Volume 26, Issue 14, pp. 1945 - 1952
This study demonstrates the use of biodegradable poly(lactide- -glycolide) (PLG) microspheres as a moldable scaffold for cartilage tissue engineering....
Cartilage tissue engineering | Cartilage repair | Microsphere | Glycosaminoglycan | PLG | Scaffold | ECM | cartilage tissue engineering | NASAL | MATERIALS SCIENCE, BIOMATERIALS | CHONDROCYTES | ENGINEERING, BIOMEDICAL | NEOCARTILAGE | CONTROLLED-RELEASE | REDIFFERENTIATION | COMPOSITES | scaffold | IN-VIVO | microsphere | DEGRADATION | LOW-OXYGEN TENSION | GROWTH-FACTOR | cartilage repair | ECM glycosaminoglycan | Chondrocytes - cytology | Cell Proliferation | Lactic Acid - chemistry | Tissue Engineering - methods | Cartilage, Articular - cytology | Biocompatible Materials - chemistry | Cells, Cultured | Cartilage, Articular - growth & development | Materials Testing | Cell Culture Techniques - methods | Absorbable Implants | Feasibility Studies | Microspheres | Animals | Chondrocytes - physiology | Cattle | Cell Adhesion - physiology | Polyglycolic Acid - chemistry | Surface Properties | Polymers - chemistry | Porosity | Cell Differentiation - physiology | Glycosaminoglycans | Tissue engineering | Collagen | Cells | Aerospace engineering
Cartilage tissue engineering | Cartilage repair | Microsphere | Glycosaminoglycan | PLG | Scaffold | ECM | cartilage tissue engineering | NASAL | MATERIALS SCIENCE, BIOMATERIALS | CHONDROCYTES | ENGINEERING, BIOMEDICAL | NEOCARTILAGE | CONTROLLED-RELEASE | REDIFFERENTIATION | COMPOSITES | scaffold | IN-VIVO | microsphere | DEGRADATION | LOW-OXYGEN TENSION | GROWTH-FACTOR | cartilage repair | ECM glycosaminoglycan | Chondrocytes - cytology | Cell Proliferation | Lactic Acid - chemistry | Tissue Engineering - methods | Cartilage, Articular - cytology | Biocompatible Materials - chemistry | Cells, Cultured | Cartilage, Articular - growth & development | Materials Testing | Cell Culture Techniques - methods | Absorbable Implants | Feasibility Studies | Microspheres | Animals | Chondrocytes - physiology | Cattle | Cell Adhesion - physiology | Polyglycolic Acid - chemistry | Surface Properties | Polymers - chemistry | Porosity | Cell Differentiation - physiology | Glycosaminoglycans | Tissue engineering | Collagen | Cells | Aerospace engineering
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 05/2010, Volume 6, pp. 151 - 158
Restless legs syndrome (RLS) is a sleep-related movement disorder commonly involving an unpleasant urge to move the limbs, typically the legs. Dopaminergic...
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 1998, Volume 87, Issue 11, pp. 1406 - 1411
Journal Article
BMC Neuroscience, 12/2008, Volume 9, Issue 3
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 501 - 501
Journal Article
Drug Development Research, ISSN 0272-4391, 05/2008, Volume 69, Issue 3, pp. 143 - 152
Insulin is the most effective therapy for lowering glycosylated hemoglobin (A1c) levels in Type 2 diabetics, and yet it is typically the last therapeutic...
Type 2 diabetes | postprandial hyperglycemia | intranasal insulin | Intranasal insulin | Postprandial hyperglycemia | INHALED INSULIN | GLYCEMIC CONTROL | CHEMISTRY, MEDICINAL | DOSE-RESPONSE | HEALTHY-SUBJECTS | DRUG-DELIVERY | MELLITUS | COMPARATIVE TRIAL | INTESTINAL-ABSORPTION | THERAPY | GLARGINE | PHARMACOLOGY & PHARMACY
Type 2 diabetes | postprandial hyperglycemia | intranasal insulin | Intranasal insulin | Postprandial hyperglycemia | INHALED INSULIN | GLYCEMIC CONTROL | CHEMISTRY, MEDICINAL | DOSE-RESPONSE | HEALTHY-SUBJECTS | DRUG-DELIVERY | MELLITUS | COMPARATIVE TRIAL | INTESTINAL-ABSORPTION | THERAPY | GLARGINE | PHARMACOLOGY & PHARMACY
Journal Article
11.
Full Text
Discovery of tight junction modulators: significance for drug development and delivery
Drug Discovery Today, ISSN 1359-6446, 2008, Volume 13, Issue 5, pp. 261 - 267
Tight junction biology has many important applications, from improving knowledge of diseases characterized by the loss of epithelial or endothelial tissue...
ZONULA OCCLUDENS TOXIN | PROTEIN | EPITHELIAL-CELLS | PERMEABILITY | INFLAMMATION | TETRADECYLMALTOSIDE | PHARMACOLOGY & PHARMACY | INTRANASAL DELIVERY | ENDOCYTOSIS | PLASMA-MEMBRANE | PEPTIDE | Epithelium - drug effects | Peptides - chemistry | Signal Transduction | Humans | Models, Molecular | Epithelium - ultrastructure | Chemistry, Pharmaceutical | Drug Delivery Systems | Peptides - pharmacology | Tight Junctions - ultrastructure | Endocytosis | Tight Junctions - physiology | Animals | Combinatorial Chemistry Techniques | Cell Adhesion - physiology | Drug Design | Epithelium - physiology | Tight Junctions - drug effects | Index Medicus
ZONULA OCCLUDENS TOXIN | PROTEIN | EPITHELIAL-CELLS | PERMEABILITY | INFLAMMATION | TETRADECYLMALTOSIDE | PHARMACOLOGY & PHARMACY | INTRANASAL DELIVERY | ENDOCYTOSIS | PLASMA-MEMBRANE | PEPTIDE | Epithelium - drug effects | Peptides - chemistry | Signal Transduction | Humans | Models, Molecular | Epithelium - ultrastructure | Chemistry, Pharmaceutical | Drug Delivery Systems | Peptides - pharmacology | Tight Junctions - ultrastructure | Endocytosis | Tight Junctions - physiology | Animals | Combinatorial Chemistry Techniques | Cell Adhesion - physiology | Drug Design | Epithelium - physiology | Tight Junctions - drug effects | Index Medicus
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 03/2002, Volume 54, Issue 3, pp. 301 - 313
Sustained release of pharmaceutical proteins from biocompatible polymers offers new opportunities in the treatment and prevention of disease. The manufacturing...
HUMAN GROWTH-HORMONE | BIODEGRADABLE MICROSPHERES | ORGANIC-SOLVENTS | LYOPHILIZED PROTEIN | DRUG-DELIVERY | PLGA MICROSPHERES | PHARMACOLOGY & PHARMACY | MOISTURE-INDUCED AGGREGATION | SECONDARY STRUCTURE | INFRARED-SPECTROSCOPY | SOLID-STATE | Biocompatible Materials | Polymers - chemistry | Proteins - chemistry | Delayed-Action Preparations | Chemistry, Pharmaceutical - trends
HUMAN GROWTH-HORMONE | BIODEGRADABLE MICROSPHERES | ORGANIC-SOLVENTS | LYOPHILIZED PROTEIN | DRUG-DELIVERY | PLGA MICROSPHERES | PHARMACOLOGY & PHARMACY | MOISTURE-INDUCED AGGREGATION | SECONDARY STRUCTURE | INFRARED-SPECTROSCOPY | SOLID-STATE | Biocompatible Materials | Polymers - chemistry | Proteins - chemistry | Delayed-Action Preparations | Chemistry, Pharmaceutical - trends
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2001, Volume 76, Issue 3, pp. 199 - 208
Encapsulation of the model protein bovine serum albumin (BSA) into poly(D,L lactide-co-glycolide) (PLG) microspheres was performed by a non-aqueous oil-in-oil...
Microspheres | Non-aqueous encapsulation | Protein aggregation | Poly(lactide- co-glycolide) | Spray-freeze drying | Poly(lactide-co-glycolide) | non-aqueous encapsulation | poly(lactide-co-glycolide) | BIODEGRADABLE MICROSPHERES | microspheres | DRUG-DELIVERY | INFRARED-SPECTROSCOPY | CHEMISTRY, MULTIDISCIPLINARY | HUMAN GROWTH-HORMONE | ORGANIC-SOLVENTS | protein aggregation | POLYMER | PHARMACOLOGY & PHARMACY | SECONDARY STRUCTURE | ACID) MICROSPHERES | MICROENCAPSULATION | spray-freeze drying | BOVINE SERUM-ALBUMIN | Serum Albumin, Bovine - administration & dosage | Lactic Acid | Polyglycolic Acid | Freeze Drying | Solubility | Chromatography, High Pressure Liquid | Spectroscopy, Fourier Transform Infrared | Spectrophotometry, Ultraviolet | Drug Carriers | Drug Delivery Systems | Drug Compounding | Polymers | Circular Dichroism
Microspheres | Non-aqueous encapsulation | Protein aggregation | Poly(lactide- co-glycolide) | Spray-freeze drying | Poly(lactide-co-glycolide) | non-aqueous encapsulation | poly(lactide-co-glycolide) | BIODEGRADABLE MICROSPHERES | microspheres | DRUG-DELIVERY | INFRARED-SPECTROSCOPY | CHEMISTRY, MULTIDISCIPLINARY | HUMAN GROWTH-HORMONE | ORGANIC-SOLVENTS | protein aggregation | POLYMER | PHARMACOLOGY & PHARMACY | SECONDARY STRUCTURE | ACID) MICROSPHERES | MICROENCAPSULATION | spray-freeze drying | BOVINE SERUM-ALBUMIN | Serum Albumin, Bovine - administration & dosage | Lactic Acid | Polyglycolic Acid | Freeze Drying | Solubility | Chromatography, High Pressure Liquid | Spectroscopy, Fourier Transform Infrared | Spectrophotometry, Ultraviolet | Drug Carriers | Drug Delivery Systems | Drug Compounding | Polymers | Circular Dichroism
Journal Article
NEUROPSYCHIATRIC DISEASE AND TREATMENT, ISSN 1178-2021, 2010, Volume 6, Issue 1, pp. 151 - 158
Restless legs syndrome (RLS) is a sleep-related movement disorder commonly involving an unpleasant urge to move the limbs, typically the legs. Dopaminergic...
SYNDROME SYMPTOMS | AMINOMETHYL)-1-CYCLOHEXANE ACETIC-ACID | PSYCHIATRY | restless legs syndrome | CROSS-OVER | XP13512 | CLINICAL NEUROLOGY | NEUROPATHIC PAIN | movement disorder | B RECEPTORS | DOUBLE-BLIND | HEMODIALYSIS-PATIENTS | AGENT GABAPENTIN | gabapentin enacarbil | CALCIUM-CHANNEL | Restless legs syndrome | Expert Opinion
SYNDROME SYMPTOMS | AMINOMETHYL)-1-CYCLOHEXANE ACETIC-ACID | PSYCHIATRY | restless legs syndrome | CROSS-OVER | XP13512 | CLINICAL NEUROLOGY | NEUROPATHIC PAIN | movement disorder | B RECEPTORS | DOUBLE-BLIND | HEMODIALYSIS-PATIENTS | AGENT GABAPENTIN | gabapentin enacarbil | CALCIUM-CHANNEL | Restless legs syndrome | Expert Opinion
Journal Article